Overview Financials News + Filings Key Docs Charts Transactions Holdings Ownership Insiders
|
| In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
| | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
| Revenues: |
| Corporate | 317.0 | 269.0 | 343.0 | 285.0 | 383.0 | | | 309.0 |
| Performance Plastics | | | | | | | | 22,386.0 |
| Health and Agricultural Sciences | | | | | | | | 7,290.0 |
| Other | 54,651.0 | 38,273.0 | 42,608.0 | 49,319.0 | 43,347.0 | | | 28,182.0 |
| Total revenues | 54,968.0 | 38,542.0 | 42,951.0 | 49,604.0 | 43,730.0 | 48,158.0 | 48,778.0 | 58,167.0 |
| Revenue growth [+] | 42.6% | -10.3% | -13.4% | 13.4% | -9.2% | -1.3% | -16.1% | 1.9% |
| Corporate | 17.8% | -21.6% | 20.4% | -25.6% | | | | |
| Cost of goods sold | 44,191.0 | 33,346.0 | 36,657.0 | 41,074.0 | 36,350.0 | 37,668.0 | 37,745.0 | 47,464.0 |
| Gross profit | 10,777.0 | 5,196.0 | 6,294.0 | 8,530.0 | 7,380.0 | 10,490.0 | 11,033.0 | 10,703.0 |
| Gross margin | 19.6% | 13.5% | 14.7% | 17.2% | 16.9% | 21.8% | 22.6% | 18.4% |
| Selling, general and administrative | 1,645.0 | 1,471.0 | 1,590.0 | 1,782.0 | 1,795.0 | 2,953.0 | 2,948.0 | 3,106.0 |
| Research and development | 857.0 | 768.0 | 765.0 | 800.0 | 803.0 | 1,593.0 | 1,598.0 | 1,647.0 |
| Equity in earnings | 975.0 | -18.0 | -94.0 | 555.0 | 394.0 | 442.0 | 674.0 | 835.0 |
| Other operating expenses | 629.0 | -1,371.0 | 4,777.0 | 2,315.0 | 4,227.0 | -1,097.0 | -4,492.0 | |
| EBITDA [+] | 11,075.0 | 6,783.0 | 1,587.0 | 6,628.0 | 3,095.0 | 10,345.0 | 14,174.0 | 6,825.0 |
| EBITDA growth | 63.3% | 327.4% | -76.1% | 114.2% | -70.1% | -27.0% | 107.7% | -15.5% |
| EBITDA margin | 20.1% | 17.6% | 3.7% | 13.4% | 7.1% | 21.5% | 29.1% | 11.7% |
| Depreciation and amortization | 2,454.0 | 2,473.0 | 2,519.0 | 2,440.0 | 2,146.0 | 2,318.0 | 2,102.0 | 2,311.0 |
| EBITA | 8,621.0 | 4,310.0 | -932.0 | 4,188.0 | 949.0 | 8,027.0 | 12,072.0 | 4,514.0 |
| EBITA margin | 15.7% | 11.2% | -2.2% | 8.4% | 2.2% | 16.7% | 24.7% | 7.8% |
| Amortization of intangibles | 388.0 | 401.0 | 419.0 | 469.0 | 400.0 | 544.0 | 419.0 | 436.0 |
| EBIT [+] | 8,233.0 | 3,909.0 | -1,351.0 | 3,719.0 | 549.0 | 7,483.0 | 11,653.0 | 4,078.0 |
| EBIT growth | 110.6% | -389.3% | -136.3% | 577.4% | -92.7% | -35.8% | 185.8% | -24.4% |
| EBIT margin | 15.0% | 10.1% | -3.1% | 7.5% | 1.3% | 15.5% | 23.9% | 7.0% |
| Non-recurring items [+] | -691.0 | 853.0 | -1,463.0 | -1,105.0 | -633.0 | 1,708.0 | 559.0 | 125.0 |
| Asset impairment | 6.0 | 708.0 | 3,219.0 | 221.0 | 2,739.0 | 595.0 | 559.0 | 50.0 |
| Restructuring charges | | | | | | | | -3.0 |
| Unusual expense | -697.0 | 145.0 | -4,682.0 | -1,326.0 | -3,372.0 | 1,113.0 | | 78.0 |
| Interest expense, net [+] | 676.0 | 789.0 | 852.0 | 981.0 | 848.0 | 751.0 | 875.0 | 932.0 |
| Interest expense | 731.0 | 827.0 | 933.0 | 1,063.0 | 914.0 | 858.0 | 946.0 | 983.0 |
| Interest income | 55.0 | 38.0 | 81.0 | 82.0 | 66.0 | 107.0 | 71.0 | 51.0 |
| Other income (expense), net | -103.0 | -196.0 | -507.0 | -94.0 | -97.0 | -611.0 | -289.0 | 2,244.0 |
| Pre-tax income | 8,145.0 | 2,071.0 | -1,247.0 | 3,749.0 | 237.0 | 4,413.0 | 9,930.0 | 5,265.0 |
| Income taxes | 1,740.0 | 777.0 | 470.0 | 809.0 | 1,524.0 | 9.0 | 2,147.0 | 1,426.0 |
| Tax rate | 21.4% | 37.5% | | 21.6% | 643.0% | 0.2% | 21.6% | 27.1% |
| Minority interest | 94.0 | 69.0 | 87.0 | 134.0 | 130.0 | 86.0 | 98.0 | 67.0 |
| Net income | 6,311.0 | 1,225.0 | -1,359.0 | 4,641.0 | 465.0 | 3,978.0 | 7,345.0 | 3,432.0 |
| Net margin | 11.5% | 3.2% | -3.2% | 9.4% | 1.1% | 8.3% | 15.1% | 5.9% |
| |
| Basic EPS [+] | $8.49 | $1.65 | ($1.83) | $6.21 | $0.62 | $3.57 | $6.50 | $2.93 |
| Growth | 413.0% | -190.4% | -129.5% | 894.9% | -82.5% | -45.1% | 121.7% | -21.8% |
| Diluted EPS [+] | $8.43 | $1.65 | ($1.83) | $6.21 | $0.62 | $3.52 | $5.92 | $2.89 |
| Growth | 410.6% | -190.2% | -129.5% | 894.9% | -82.3% | -40.5% | 104.6% | -16.1% |
| |
| Dividends per share [+] | $2.80 | $2.80 | $2.10 | $0.38 | $1.38 | $1.84 | $1.72 | $1.53 |
| Growth | 0.0% | 33.3% | 452.6% | -72.5% | -25.0% | 7.0% | 12.4% | 19.5% |
| |
| Shares outstanding (basic) [+] | 743.6 | 740.5 | 742.5 | 747.2 | 744.8 | 1,114.3 | 1,130.1 | 1,170.9 |
| Growth | 0.4% | -0.3% | -0.6% | 0.3% | -33.2% | -1.4% | -3.5% | -1.3% |
| Shares outstanding (diluted) [+] | 749.0 | 742.3 | 742.5 | 747.2 | 744.8 | 1,130.1 | 1,241.4 | 1,187.0 |
| Growth | 0.9% | 0.0% | -0.6% | 0.3% | -34.1% | -9.0% | 4.6% | -8.0% |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|